- 专利标题： Hepatitis B core protein modulators
-
申请号： US15760284申请日： 2016-09-15
-
公开(公告)号： US10377748B2公开(公告)日： 2019-08-13
- 发明人: William Turner , Lee Daniel Arnold , Hans Maag , Leping Li , Mark Bures , Simon Haydar , Samson Francis
- 申请人： Assembly Biosciences, Inc. , INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
- 申请人地址： US IN Carmel US IN Indianapolis
- 专利权人： Assembly Biosciences, Inc.,Indiana University Research And Technology Corporation
- 当前专利权人： Assembly Biosciences, Inc.,Indiana University Research And Technology Corporation
- 当前专利权人地址： US IN Carmel US IN Indianapolis
- 代理机构： Goodwin Procter LLP
- 国际申请： PCT/US2016/051934 WO 20160915
- 国际公布： WO2017/048950 WO 20170323
- 主分类号： C07D417/12
- IPC分类号： C07D417/12 ; A61P31/20 ; C07D403/12 ; A61K45/06 ; C07D401/12 ; C07D413/12 ; C07D417/14 ; C07D453/02 ; C07D471/04 ; C07D243/38 ; C07D267/20 ; C07D281/16
摘要：
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
公开/授权文献
- US20180258084A1 HEPATITIS B CORE PROTEIN MODULATORS 公开/授权日：2018-09-13
信息查询
